Article Details

Vir Biotechnology to Participate in the HC Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference

Retrieved on: 2022-10-11 20:22:35

Tags for this article:

Click the tags to see associated articles and topics

Vir Biotechnology to Participate in the HC Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference. View article details on hiswai:

Excerpt

SAN FRANCISCO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., executive vice ...

Article found on: stockhouse.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up